07:39, 09/12/2022 cOASIS, The Online Abstract Submission System

Print this Page for Your Records Close Window

Control/Tracking Number: 23-A-42-ISMICS

Activity: Abstract
Current Date/Time: 12/8/2022 6:39:33 PM

Minimally Invasive Tricuspid Valve Surgery A Single Institution Experience

Author Block: NGUYEN Tran Thuy, Sr.1, Ngoc Thanh LE1, Cong Huu Nguyen2, Van Trung Hoang2, The Binh Nguyen2, Thao Nguyen Phan2, Anh Tien Do1.
1University of Medicine and Pharmacy, VNU, Hanoi, Viet Nam, 2Cardiovascular Center, E - Hospital, Hanoi, Viet Nam.

Abstract:
BACKGROUND:Tricuspid regurgitation is one of the most common heart valve diseases, affecting 65-85% of the population. Primary tricuspid regurgitation
has causes in the tricuspid valve including rheumatic, degenerative, congenital, infectious, etc. Secondary tricuspid regurgitation is more common,
associated with right ventricular dysfunction, dilated annulus. valves, often secondary to left-sided valve disease (especially mitral valve disease), atrial
fibrillation, and pulmonary hypertension. Traditional sternal open surgery has the advantage of being spacious and convenient for technical manipulations,
but the method still has many traumas and risks of sternum inflammation. Endoscopic surgery avoids opening the sternum with the advantages of
minimizing trauma, eliminating sternitis, being more aesthetic is becoming a trend and is increasingly applied in cardiovascular surgery.Aims: Evaluation of
early and medium-term results of endoscopic surgery for tricuspid valve disease at cardiovascular center, E Hospital METHODS:Cross-sectional descriptive
study, data were collected retrospectively and prospectively RESULTS:From January 2020 to December 2021, we studied 42 patients undergoing endoscopic
surgery for tricuspid valve disease, including 13 men (31%), 29 women (69%). Average age is 53.98±12.51 years. The number of patients with tricuspid valve
repair and mitral valve replacement surgery was 34 patients, the number of patients with tricuspid valve repair after mitral valve replacement surgery was 4
patients, there were 2 patients with severe tricuspid regurgitation due to infective endocarditis . There was 1 patient with tricuspid valve repair combined
with atrial septal defect patching. Immediately after surgery, the proportion of patients with no regurgitation or mild regurgitation of the tricuspid valve was
35 patients (83.3%), moderate regurgitation had 6 patients (14.3%), severe regurgitation had 1 patient (2.4%) ), 41 patients (97.6%) were discharged from
https://www.abstractsonline.com/cSubmit/SubmitPrinterFriendlyVersion.asp?ControlKey=81164AB0-5EF0-4745-AA67-78AE7262492B&MeetingActivityKey=%7BFEE87073-4E14-4DAC-BD19-F7F9245… 1/3
07:39, 09/12/2022 cOASIS, The Online Abstract Submission System

hospital, 1 patient (2.4%) died early after surgery. The longest follow-up time was 17 months, the shortest was 6 months, the results were no longer tricuspid
regurgitation or mild regurgitation in 37 patients (90.2%), moderate regurgitation in 4 patients (9.8%), there aren’t patients with severe regurgitation of the
tricuspid valve or late death. CONCLUSIONS:Endoscopic surgery for the treatment of tricuspid valve disease has good results, aesthetics, few
complications.Keywords: Endoscopic, tricuspid valve

Author Disclosure Information:

N. T. Thuy, None..
N. Le, None..
C. Nguyen, None..
V. Hoang, None..
T. Nguyen, None..
T. Phan, None..
A. Do, None.
Topic (Complete): Valve - Surgical Valves
Content Validation (Complete):
Has your work been presented at another meeting before?: No
* I understand that my activity materials may be peer reviewed prior to the activity occurring (or being released) for fair balance and to validate

https://www.abstractsonline.com/cSubmit/SubmitPrinterFriendlyVersion.asp?ControlKey=81164AB0-5EF0-4745-AA67-78AE7262492B&MeetingActivityKey=%7BFEE87073-4E14-4DAC-BD19-F7F9245… 2/3
07:39, 09/12/2022 cOASIS, The Online Abstract Submission System

content. : yes
* I understand that my live presentation (if applicable) and/or activity materials will be evaluated by participants for fair balance and that
enduring materials (if applicable) will be peer-reviewed for fair balance. : yes
* I attest that any and all clinical recommendations that I make for patient care as part of my planning and/or activity materials will be based on
the best available evidence, that a balanced view of therapeutic options will be given. : yes

ACCME Practice Gaps Requirement (Complete):

1. What professional practice gap does this abstract address?
(A practice gap is the difference between actual and ideal performance and may include the difference between actual and ideal patient outcomes.)
: NO
2. How will this abstract influence change in competence, performance or patient outcomes?
: Good

Presentation Preference (Complete): Oral Presentation, ePoster Competition or ePoster

Awards (Complete):
Are you applying for the Subramanian Innovation Award?: No
Are you applying for the Gründeman Scientific Research Award?: No
Are you applying for The Cardiac Robotic Young Investigator Award?: No

Attached Files: No Files Attached

Status: Complete

International Society for Minimally Invasive Cardiothoracic Surgery

500 Cummings Center
Suite 4400
Beverly, MA 01915
Phone: 978 927 8330

FOR TECHNICAL SUPPORT:

217-398-1792 (Monday through Friday 8:00 am-5:00 pm Central Standard Time)
or ismics@support.ctimeetingtech.com

 Feedback

Powered by cOASIS, The Online Abstract Submission and Invitation System SM

© 1996 - 2022 CTI Meeting Technology All rights reserved. Privacy Policy

https://www.abstractsonline.com/cSubmit/SubmitPrinterFriendlyVersion.asp?ControlKey=81164AB0-5EF0-4745-AA67-78AE7262492B&MeetingActivityKey=%7BFEE87073-4E14-4DAC-BD19-F7F9245… 3/3